Maker of CryoStor freeze media used in most approved cell therapies, plus evo cold-chain shippers.
BioLife Solutions, based in Bothell, Washington, and listed as BLFS, makes the CryoStor freeze media used in most approved cell therapies, plus evo cold-chain shippers. It divested its freezer hardware lines in 2024 to focus on biopreservation media and consumables. OnCo links it to cryopreservation and the cell therapy cold chain. Whether a consumables supplier embedded in approved manufacturing processes can be displaced, given the cost of revalidation, is the fair question. The cold chain technology page carries the wider picture.
Shares Cryopreservation and cell-therapy cold chain and the tag supporting.
Shares Cryopreservation and cell-therapy cold chain and the tag supporting.
Shares Cryopreservation and cell-therapy cold chain and the tag supporting.
Shares Cryopreservation and cell-therapy cold chain and the tag supporting.